DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Ausgabe 05 · Volume 57 · Mai 2019 DOI: 10.1055/s-009-43057

Österreichische Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH)
52. Jahrestagung & 30. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH)
Innsbruck, 13.–15.06.2019

Kongresspräsident: Univ.-Prof. Dr. Herbert Tilg Kongresssekretäre: Univ-Prof. Dr. Robert Koch Univ.-Prof. Dr. Heinz Zoller Fortbildungskurs: Univ.-Prof. Dr. Peter Ferenci Prim. Univ.-Prof. Dr. Michael Gschwantler
Abstracts (HTML) Autorenliste
P01
Gröchenig, HP; Walter, E; Redl, A; Bresztowanszky, M; Steidl, K; Siebert, F; Novacek, G: Real World Assessment of Biological Treatment of Inflammatory Bowel Disease at an Austrian Referral Centre: The ULTIMATE Study
P02
Mayr, L; Grabherr, F; Schwärzler, J; Reitmeier, I; Gehmacher, T; Niederreiter, L; Ran, Q; Moschen, A; Kaser, A; Tilg, H; Adolph, T: Polyunsaturated fatty acids fuel intestinal inflammation in GPX4 deficient hosts
P03
Texler, B; Macheiner, S; Reider, S; Schwabegger, C; Pfister, A; Tilg, H; Moschen, AR: Selektive Effekte unterschiedlicher Janus Kinase Inhibitoren auf spezifische intestinale Zellpopulationen
P04
Novacek, G; Reinisch, W; Reinisch, S; Primas, C; Eigner, W; Vogelsang, H; Dejaco, C; Kazemi-Shirazi, L; Niapir, M; Mekhail, P; Pedarnig, N; Angermann, H; Waldhör, T: Risk factors for first intestinal surgery in Crohn's disease
P05
van Assche, G; Targan, SR; Baker, T; O'Brien, CD; Zhang, H; Johanns, J; Szapary, P; Marano, C; Rupert, LW; Rowbotham, D; Hisamatsu, T; Danese, S; Sands, BE; Peyrin-Biroulet, L: Sustained Remission in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 UNIFI Maintenance Study
P06
Sandborn, WJ; Sands, BE; Panaccione, R; O'Brien, CD; Zhang, H; Johanns, J; Peyrin-Biroulet, L; van Assche, G; Danese, S; Targan, S; Abreu, MT; Hisamatsu, T; Szapary, P; Marano, C: Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
P07
Li, K; Joshua, FR; Marano, C; Zhang, H; Yang, F; Feagan, BG; Peyrin-Biroulet, L; De Hertogh, G: Effects of Ustekinumab Induction Therapy on Endoscopic and Histologic Healing in the UNIFI Phase 3 Study in Ulcerative Colitis
P08
Li, K; Yang, F; Hayden, K; Strawn, D; Wadman, E; Bhagat, S; Marano, C; Friedman, JR: Molecular Response to Ustekinumab in Moderate-to-severe Ulcerative Colitis by Serum Protein and Biopsy Gene Expression Analysis: Results from the UNIFI Phase 3 Induction Study
P09
Sands, BE; Peyrin-Biroulet, L; Marano, C; O'Brien, CD; Zhang, H; Johanns, J; Szapary, P; Rowbotham, D; Leong, RW; Arasaradnam, RP; Danese, S; van Assche, G; Targan, S; Sandborn, WJ: Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI
P10
Krainer, M; Sommer, J; Silbert-Wagner, D; Racedo, S; Panzitt, K; Wagner, M: Does the gut microbiome affect intestinal steroidogenesis?
P11
Zollner, A; Schmiderer, A; Reider, S; Koch, R; Oberhuber, G; Effenberger, M; Pfister, A; Tilg, H; Moschen, A: Calprotectin versus Lipocalin 2 bei chronisch entzündlichen Darmerkrankungen